RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,000 | -94.4% | 541 | -91.7% | 0.00% | – |
| Q4 2020 | $18,000 | – | 6,536 | +2375.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 264 | -88.8% | 0.00% | – |
| Q3 2019 | $26,000 | -88.0% | 2,350 | -89.0% | 0.00% | -100.0% |
| Q2 2019 | $217,000 | +93.8% | 21,402 | +11.7% | 0.00% | – |
| Q1 2019 | $112,000 | +489.5% | 19,160 | +585.3% | 0.00% | – |
| Q4 2018 | $19,000 | +850.0% | 2,796 | +577.0% | 0.00% | – |
| Q2 2018 | $2,000 | -50.0% | 413 | -4.6% | 0.00% | – |
| Q4 2017 | $4,000 | +100.0% | 433 | +19.3% | 0.00% | – |
| Q2 2017 | $2,000 | – | 363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |